{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:22:28Z","timestamp":1778127748866,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bjaopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BJA Open"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bjao.2025.100415","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T19:13:45Z","timestamp":1749150825000},"page":"100415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Systemic role of orexin A, substance P, bradykinin, and DABK in severe COVID-19 and 2.5-yr follow-ups: an observational study"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-8124","authenticated-orcid":false,"given":"Ulrike","family":"Heinicke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippos","family":"Thanasis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth H.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"von Knethen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea U.","family":"Steinbicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-3828","authenticated-orcid":false,"given":"Sebastian","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-9110","authenticated-orcid":false,"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin N.","family":"Flinspach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjao.2025.100415_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bjao.2025.100415_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrn3837","article-title":"The role of orexin in motivated behaviours","volume":"15","author":"Sakurai","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bjao.2025.100415_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/NSS.S201994","article-title":"Targeting orexin receptors for the treatment of insomnia: from physiological mechanisms to current clinical evidence and recommendations","volume":"15","author":"Mogavero","year":"2023","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.bjao.2025.100415_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","article-title":"The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bjao.2025.100415_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bjao.2025.100415_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/med.21326","article-title":"The hypocretin\/orexin system: an increasingly important role in neuropsychiatry","volume":"35","author":"Chen","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bjao.2025.100415_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/1871527311312050010","article-title":"Neuropeptide systems and schizophrenia","volume":"12","author":"LaCrosse","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.bjao.2025.100415_bib8","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2147\/NDT.S209023","article-title":"Reduced plasma orexin-A concentrations in patients with bipolar disorder","volume":"15","author":"Tsuchimine","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.bjao.2025.100415_bib9","doi-asserted-by":"crossref","first-page":"1180720","DOI":"10.3389\/fpsyt.2023.1180720","article-title":"Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function","volume":"14","author":"Yu","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bjao.2025.100415_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bjao.2025.100415_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bjao.2025.100415_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1378\/chest.124.4.1381","article-title":"Plasma orexin-A concentrations in obstructive sleep apnea-hypopnea syndrome","volume":"124","author":"Igarashi","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.bjao.2025.100415_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(03)00206-5","article-title":"Orexin-A expression in human peripheral tissues","volume":"205","author":"Nakabayashi","year":"2003","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 6","key":"10.1016\/j.bjao.2025.100415_bib14","first-page":"17","article-title":"Central and local (enteric) action of orexins","volume":"57","author":"Korczynski","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.bjao.2025.100415_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.regpep.2004.07.010","article-title":"Expression of orexin receptors in the brain and peripheral tissues of the male sheep","volume":"124","author":"Zhang","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.bjao.2025.100415_bib16","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/JIR.S308078","article-title":"Orexin-A attenuates inflammatory responses in lipopolysaccharide-induced neural stem cells by regulating NF-KB and phosphorylation of MAPK\/P38\/Erk pathways","volume":"14","author":"Ye","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.bjao.2025.100415_bib17","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.bbadis.2018.08.023","article-title":"Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A","volume":"1864","author":"Messal","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.bjao.2025.100415_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-019-1447-y","article-title":"Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation","volume":"16","author":"Becquet","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bjao.2025.100415_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopha.2018.07.159","article-title":"Orexin A may suppress inflammatory response in fibroblast-like synoviocytes","volume":"107","author":"Sun","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bjao.2025.100415_bib20","unstructured":"COVID-19 epidemiological update. Available from https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-170 (accessed 26 May 2025)"},{"key":"10.1016\/j.bjao.2025.100415_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjao.2025.100415_bib22","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bjao.2025.100415_bib23","doi-asserted-by":"crossref","first-page":"e0253778","DOI":"10.1371\/journal.pone.0253778","article-title":"High sedation needs of critically ill COVID-19 ARDS patients-a monocentric observational study","volume":"16","author":"Flinspach","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bjao.2025.100415_bib24","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/CCM.0000000000005053","article-title":"Association of sedation, coma, and in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019-related acute respiratory distress syndrome: a retrospective cohort study","volume":"49","author":"Wongtangman","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjao.2025.100415_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/jcm11030588","article-title":"Associated factors of high sedative requirements within patients with moderate to severe COVID-19 ARDS","volume":"11","author":"Flinspach","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bjao.2025.100415_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/ANA.0000000000000837","article-title":"Frontal electroencephalography findings in critically ill COVID-19 patients","volume":"35","author":"Chang","year":"2023","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.bjao.2025.100415_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ncp.10645","article-title":"Nutrition support in patients with acute respiratory distress syndrome COVID-19","volume":"36","author":"Formenti","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.bjao.2025.100415_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/SHK.0000000000002231","article-title":"Evidence from fatal COVID-19 for targeting the bradykinin metabolism-a single-center cohort study","volume":"60","author":"Zinn","year":"2023","journal-title":"Shock"},{"key":"10.1016\/j.bjao.2025.100415_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/B978-0-12-381298-8.00030-7","article-title":"Measurement of orexin (hypocretin) and substance P effects on constitutively active inward rectifier K(+) channels in brain neurons","volume":"484","author":"Nakajima","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bjao.2025.100415_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/264081a0","article-title":"Release and metabolism of substance P in rat hypothalamus","volume":"264","author":"Iversen","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.bjao.2025.100415_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0306-4492(82)90081-8","article-title":"Neuropharmacology in the brain slice: effects of substance P on neurons in the guinea-pig hypothalamus","volume":"72","author":"Ogata","year":"1982","journal-title":"Comp Biochem Physiol C Comp Pharmacol"},{"key":"10.1016\/j.bjao.2025.100415_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0006-8993(77)90323-7","article-title":"Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain","volume":"119","author":"Kanazawa","year":"1977","journal-title":"Brain Res"},{"key":"10.1016\/j.bjao.2025.100415_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1515\/biol-2021-0001","article-title":"Research progress on the mechanism of orexin in pain regulation in different brain regions","volume":"16","author":"Kang","year":"2021","journal-title":"Open Life Sci"},{"key":"10.1016\/j.bjao.2025.100415_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13011","article-title":"Sympathetic nerve activity and neuro-inflammation: Who is in the driver's seat?","volume":"222","author":"Mukerjee","year":"2018","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.bjao.2025.100415_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001756-200501190-00002","article-title":"Persistent pain and stress activate pain-inhibitory orexin pathways","volume":"16","author":"Watanabe","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.bjao.2025.100415_bib36","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.bjao.2025.100415_bib37","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"key":"10.1016\/j.bjao.2025.100415_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1213\/ANE.0000000000004006","article-title":"Escape from oblivion: neural mechanisms of emergence from general anesthesia","volume":"128","author":"Kelz","year":"2019","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.bjao.2025.100415_bib39","article-title":"Plasma orexin A does not reflect severity of illness in the intensive care units patients with systemic inflammation","volume":"8","author":"Akaishi","year":"2022","journal-title":"JA Clin Rep"},{"key":"10.1016\/j.bjao.2025.100415_bib40","doi-asserted-by":"crossref","first-page":"e21055","DOI":"10.7554\/eLife.21055","article-title":"Peripherally administered orexin improves survival of mice with endotoxin shock","volume":"5","author":"Ogawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bjao.2025.100415_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13104-022-06121-0","article-title":"Reduced CSF orexin concentrations in rats and patients with systemic inflammation: a preliminary study","volume":"15","author":"Ogawa","year":"2022","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.bjao.2025.100415_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-024-03111-w","article-title":"Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice","volume":"21","author":"Guo","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bjao.2025.100415_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/10600280221147695","article-title":"Comparison of sedation and analgesia requirements in patients with SARS-CoV-2 versus non-SARS-CoV-2 acute respiratory distress syndrome on veno-venous ECMO","volume":"57","author":"Sigala","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bjao.2025.100415_bib44","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.3390\/jcm11123494","article-title":"Electroencephalogram-based evaluation of impaired sedation in patients with moderate to severe COVID-19 ARDS","volume":"11","author":"Flinspach","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bjao.2025.100415_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0306-4522(03)00554-2","article-title":"Orexinergic neurons and barbiturate anesthesia","volume":"121","author":"Kushikata","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.bjao.2025.100415_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00540-010-1071-6","article-title":"Effects of orexin-A on propofol anesthesia in rats","volume":"25","author":"Shirasaka","year":"2011","journal-title":"J Anesth"},{"key":"10.1016\/j.bjao.2025.100415_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.npep.2016.02.003","article-title":"Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain","volume":"58","author":"Zhang","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bjao.2025.100415_bib48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/bja\/aeq098","article-title":"Changes in plasma orexin A during propofol-fentanyl anaesthesia in patients undergoing eye surgery","volume":"104","author":"Kushikata","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2025.100415_bib49","doi-asserted-by":"crossref","first-page":"R692","DOI":"10.1152\/ajpregu.2000.278.3.R692","article-title":"Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats","volume":"278","author":"Chen","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bjao.2025.100415_bib50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12028-022-01565-5","article-title":"Processed electroencephalogram-based monitoring to guide sedation in critically ill adult patients: recommendations from an international expert panel-based consensus","volume":"38","author":"Rasulo","year":"2023","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjao.2025.100415_bib51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bbi.2022.12.017","article-title":"Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction","volume":"108","author":"Schirinzi","year":"2023","journal-title":"Brain Behav Immun"}],"container-title":["BJA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609625000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609625000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T03:53:33Z","timestamp":1750910013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772609625000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S2772609625000395"],"URL":"https:\/\/doi.org\/10.1016\/j.bjao.2025.100415","relation":{},"ISSN":["2772-6096"],"issn-type":[{"value":"2772-6096","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic role of orexin A, substance P, bradykinin, and DABK in severe COVID-19 and 2.5-yr follow-ups: an observational study","name":"articletitle","label":"Article Title"},{"value":"BJA Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjao.2025.100415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}],"article-number":"100415"}}